Sivaraman Jayanthi
Overview
Explore the profile of Sivaraman Jayanthi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sultania A, Brahadeeswaran S, Kolasseri A, Jayanthi S, Tamizhselvi R
J Ovarian Res
. 2025 Jan;
18(1):12.
PMID: 39849635
Extracellular vesicles, or exosomes, are produced by every type of cell and contain metabolites, proteins, lipids, and nucleic acids. Their role in health and disease is to influence different aspects...
2.
Raj A, Chakravorty A, Luktuke S, Santra S, Das S, Sahoo S, et al.
Curr Comput Aided Drug Des
. 2024 Oct;
PMID: 39415588
Background: Plants represent a rich reservoir of bioactive compounds with established therapeutic value in diverse diseases. Notably, the Toll-like receptor-4 (TLR-4) signaling pathway plays a pivotal role in inflammation. Upon...
3.
Rambabu M, Konageni N, Vasudevan K, Dasegowda K, Gokul A, Jayanthi S, et al.
Saudi J Biol Sci
. 2023 Oct;
30(11):103819.
PMID: 37860809
Pancreatic cancer shows malignancy around the world standing in 4th position for causing death globally. This cancer is majorly divided into exocrine and neuroendocrine where exocrine pancreatic ductal adenocarcinoma is...
4.
Devaraji V, Jayanthi S
RSC Adv
. 2023 Jul;
13(29):20282-20297.
PMID: 37425633
Insulin administered orally has a limited therapeutic profile due to factors such as digestion enzymes, pH, temperature, and acidic conditions in the gastrointestinal tract. Type 1 diabetes patients are typically...
5.
Nwaefulu O, Al-Shari N, Owolabi J, Sagineedu S, Woei L, Wai L, et al.
J Mol Model
. 2022 Oct;
28(11):340.
PMID: 36194315
Cancer is imposing a global health burden because of the steady increase in new cases. Moreover, current anticancer therapeutics are associated with many drawbacks, mainly the emergence of resistance and...
6.
Sethi A, Sanam S, Munagalasetty S, Jayanthi S, Alvala M
RSC Adv
. 2022 May;
10(50):29873-29884.
PMID: 35518264
The Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) has been rapidly transmitting and leaving its footprints across the globe. Stringent measures like complete lockdown and extensive testing have been...
7.
Muhammad I, Rahman N, Gul-E-Nayab , Niaz S, Basharat Z, Rastrelli L, et al.
Comput Biol Med
. 2021 Apr;
133:104362.
PMID: 33894500
Background: COVID-19, declared a pandemic in March 2020 by the World Health Organization is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The virus has already killed more than...
8.
Daraji D, Rajani D, Rajani S, Pithawala E, Jayanthi S, Patel H
Bioorg Med Chem Lett
. 2021 Jan;
36:127819.
PMID: 33513385
In this study, we have designed and synthesized 2-((5-acetyl-1-(phenyl)-4-methyl-1H-imidazol-2-yl)thio)-N-(4-((benzyl)oxy)phenyl) acetamide derivatives. Antimicrobial activities of all the imidazole derivatives have been examined against Gram-positive and Gram-negative bacteria and results showed that...
9.
Prakash S, Nazeer Y, Jayanthi S, Kabir M
Mol Biol Res Commun
. 2020 Dec;
9(4):155-167.
PMID: 33344662
Mutations in the ergosterol biosynthesis gene 11 () of have been frequently reported in fluconazole-resistant clinical isolates. Exploring the mutations and their effect could provide new insights into the underlying...
10.
Rambabu M, Jayanthi S
J Recept Signal Transduct Res
. 2020 Apr;
40(5):436-441.
PMID: 32321343
Claudin-4 (CLDN4) is a class of transmembrane protein in the family of tight junction (TJ) proteins. Overexpression of CLDN4 is reported in the case of ovarian cancer and epithelial malignancies....